Anirban Maitra, shared Matthew Herper’s post on X, adding:
“Excellent summary by Angus Rohan Chen
Oncology fellows and junior faculty interested in clinical trials (including critical appraisal of trial data) should read this article that summarizes all the issues with the Nature Medicine Immunotherapy time of day trial.”
Title: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial
Authors: Zhe Huang, Liang Zeng, Zhaohui Ruan, Qun Zeng et al.
Quoting Matthew Herper’s post on X:
“Study on timing cancer treatments to the morning comes under fire.
Link is attached to the post.”
Other OncoDaily featuring Anirban Maitra.